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Abstract
Objective: To estimate the annual incidence of vulvodynia-like symptoms and evaluate triggers of vulvar pain
in a sample of U.S. women.
Methods: After a 1-year interval, women who previously participated in a national vulvodynia prevalence study
were recontacted and administered a telephone questionnaire that assessed self-reported vulvodynia-like symp-
toms and triggers of symptoms.
Results: From the original cohort of 425 women, 285 (67%) participated in this follow-up study. Symptoms con-
sistent with vulvodynia occurring within 1 year of initial contact were reported by 4.7% of previously asymp-
tomatic women. Nearly 50% of the original patients again reported a history of vulvodynia-like symptoms,
with 68.6% of these as persistent over the past year. Of significance, pain or discomfort with first-time tampon
use was 2.15 times more likely (95% CI 1.0-4.62) in symptomatic women. These women were also 2.4 times
more likely (95% CI 1.29-4.53) to use a combination of tampons and pads for sanitary protection rather than
one method alone.
Conclusions: Over the course of 1 year, as many as 1 in 20 women may experience new-onset chronic genital
pain. Despite a higher likelihood of having discomfort or pain with first tampon use, symptomatic women did
not exhibit a preference for sanitary napkins. This indicates that lack of tampon use because of pain may not be
an effective screening criterion for vulvodynia. We recommend additional studies with symptomatic and diag-
nosed women to explore in more detail the issues surrounding tampon use history and chronic genital pain.
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Introduction
VULVODYNIA IS A GENERALIZED or localized vulvar painsyndrome of uncertain etiology characterized by inter-
mittent or constant discomfort or pain, with burning, sting-
ing, irritation, or rawness lasting for 6 months of longer,
which clinically is a diagnosis of exclusion.1 Factors compli-
cating diagnosis include vague symptoms,2 absence of vul-
var pathological conditions,3 clinicians unfamiliar with the
condition,4 and lack of a confirmatory diagnostic test. Al-
though vulvodynia was described in the literature in the late
1800s,5 many questions about its epidemiology and risk fac-
tors remain.
The lifetime prevalence of vulvodynia is approximately
9%–16% in the U.S. female population.6–8 Studies evaluating
vulvodynia have been limited by the lack of incidence data
that would further characterize this gynecological condition,
which affects up to 14 million women in the United States
during their lifetime.7
This follow-up national telephone survey ascertained the
1UMDNJ-Robert Wood Johnson Medical School, Piscataway, New Jersey.
2Present address: Department of Pathology, University of Virginia Heath System, Charlottesville, Virginia.
3UMDNJ-Women’s Health Institute, New Brunswick, New Jersey.
4UMDNJ-School of Public Health, Department of Epidemiology, Piscataway, New Jersey.
5Washington University, Department of Surgery, St. Louis, Missouri.
6UMDNJ-Robert Wood Johnson Medical School, Department of Psychiatry, Piscataway, New Jersey.
7Present address: New England Research Institutes, Watertown, Massachusetts.
This study was funded by a grant from the U.S. National Institutes of Child Health and Human Development (NIH grant R01-HD040119).
The NIH and Henne Group did not participate in data analysis.
*Co-first authors.
number of women who reported new vulvodynia-like symp-
toms and those who denied these symptoms 1 year after ini-
tial contact by this study team. As well, current literature
suggests that women experiencing pain with first tampon
use have an increased risk of later developing vulvodynia
compared with women not reporting pain with initial tam-
pon use.4,7,9 To explore this issue, tampon use history in this
cohort also was collected.
Materials and Methods
Approval for this study was obtained from both the Uni-
versity of Medicine and Dentistry of New Jersey (UMDNJ)
Institutional Review Board and Independent Research Con-
sulting. This is a follow-up study to the 2003 national tele-
phone survey by Arnold et al.,6 which identified 100 women
with self-reported symptoms suggestive of vulvodynia
(cases) and 325 asymptomatic women (controls). For the pur-
pose of the original study, a listed sample of U.S. phone num-
bers was purchased from Survey Sampling, Inc. (Fairfield,
CT), and used to identify participants. Controls were
matched to cases on 5-year age intervals and time zone, with
the four major U.S. time zones represented. Women were ex-
cluded if they reported an active gynecological infection or
a positive history of conditions known to mimic and com-
plicate the diagnosis of vulvodynia.6,10 Additional details
about subject selection, calling disposition, and survey ad-
ministration have been described previously.6
In this study, up to four phone calls were made on dif-
ferent weekdays and times in an attempt to recontact 424 of
the 425 women who participated in the original survey 1-
year earlier; one phone number was not recorded in the ini-
tial study, and this subject was lost to follow-up. Participants
answered a 19-item survey that lasted an average of 10
minutes. They were rescreened for symptoms of vulvodynia
using the same criteria adopted in the initial study.6 In ac-
cordance with International Society for the Study of Vulvo-
vaginal Disease (ISSVD) guidelines, vulvodynia symptoms
were defined as unexplained intermittent or constant dis-
comfort or pain, with burning, stinging, irritation, or raw-
ness lasting for 6 months or longer.1 The Henne Group (San
Francisco, CA), the research consulting firm that conducted
the initial study, implemented the follow-up questionnaire
using the Computer Aided Telephone Interviewing (CATI)
system as a means of minimizing interviewer bias. Partici-
pants’ identification as cases or controls was known to the
interviewers, as it was noted in the dataset in response to the
question assessing symptom history.
Contact, cooperation, and response rates were calculated
using the American Association for Public Opinion Research
(AAPOR) definitions.11 Chi-square, Fischer’s exact test, and
t tests were used to examine differences between popula-
tions as appropriate. Odds ratios (OR) and 95% confidence
intervals (CIs) were used to characterize associations be-
tween vulvodynia-like symptoms and tampon use variables.
SPSS 10.1 and SAS 9.1 (Cary, NC) were used for analysis,
with statistical significance set at p  0.05.
Results
Of the 425 women from the initial national prevalence sur-
vey, 318 (75%) were successfully recontacted (Table 1).
Among the 107 remaining women, 88 (or 21% of the origi-
nal sample) had either moved or disconnected their number,
thus preventing the possibility of recontact. The study ob-
tained a cooperation rate of 89.6% and a response rate of
67.2%, resulting in 285 participants. Characteristics of re-
sponders and nonresponders were examined using data
gathered in the original survey (Table 2). Significant differ-
ences were found with respect to age, marital status, level of
education, and race. Nonresponders were typically younger
than responders, with more than half 45 years of age
(54.17% vs. 35.09%). They also tended to be single or di-
vorced/separated (34.79% vs. 17.09%) and of a race other
than Caucasian or black (14.29% vs. 6.67%). Whereas more
than one third of each population had at least a college de-
gree, responders were more likely to have a graduate degree
(16.84% vs. 5.76%). Although there were no significant dif-
ferences in employment status, a higher proportion of re-
sponders were retired (24.82% vs. 13.77%). With respect to
health status, there were no significant differences in self-re-
ported quality of life, stress levels, overall health, and his-
tory of depression.
The follow-up population in this study comprised 213
original controls and 72 original cases (Fig. 1). When subjects
were reassessed for history of vulvodynia-like symptoms, 17
of the 213 controls reported ever experiencing symptoms.
Ten of these women stated symptoms occurred since the last
telephone contact, yielding an incidence of 4.7%. Seven con-
trols reported experiencing vulvodynia-like symptoms more
than 1 year ago and, therefore, were not included in the in-
cidence calculation.
It was expected that at follow-up, the 72 original cases
would again report a positive history of vulvodynia-like
symptoms; however, only 35 reconfirmed their case status
(Fig. 1), 24 (68.6%) of whom stated the most recent symp-
toms occurred within the past year. Surprisingly, 36 original
cases denied ever having symptoms, and 1 refused to an-
swer the question. As no questions were asked to determine
if this inconsistency in answers was due to a misunder-
standing of the question or inaccurate self-reporting, data
from these 37 women were not included in the follow-up
analysis in either the symptomatic or asymptomatic groups.
Thus, the follow-up analysis divided women into an asymp-
tomatic group (n  196) confined to subjects who denied
symptoms in both studies and a symptomatic group (n  52)
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TABLE 1. CALLING DISPOSITION AND CODING FOR
CALCULATING CONTACT, COOPERATION, AND RESPONSE
RATES OF 425 WOMEN IN FOLLOW-UP STUDY
Calling disposition No. of records Codea
Complete 285 I
Partial 2 P
Subject died or unavailable 18 NC
Unable to participate (physical, 3 O
mental, miscellaneous reasons)
Disconnected number 58 NC
Respondent no at residence 30 NC
Refusal––Do not call 28 R
Phone number not recorded in 1 NC
original survey
aContact reported as: I  complete interview; P  partial inter-
view; NC  noncontact; R  refusal and breakoff; O  other.
comprised of the 35 reconfirmed cases plus the 17 original
controls who reported vulvodynia-like symptoms at follow-
up.
Symptomatic and asymptomatic women were similar in
age, menopausal status, and racial distribution (Table 3). Al-
though the symptomatic group reported significantly higher
stress levels, there were no differences noted regarding qual-
ity of life and assessment of overall health. When questioned
about chronic pain or discomfort with tampon insertion,
speculum insertion, intercourse, and exercise, a significantly
higher proportion of symptomatic women reported situa-
tional pain in all four circumstances (Table 4). Notably, half
of the symptomatic group experienced dyspareunia, and
slightly more than 25% experienced pain with tampon and
speculum insertion, compared with 5% of their asympto-
matic counterparts.
Several questions were designed to investigate relation-
ships between vulvodynia-like symptoms and menstrual
history, specifically tampon use. When queried about pre-
ferred method of sanitary protection, symptomatic women
were 2.4 times as likely to report using a combination of pads
and tampons as opposed to one method alone. Of the sub-
group not using tampons, symptomatic women were nearly
twice as likely as asymptomatic women to report using only
sanitary pads during menstruation because of discomfort
with tampon use (OR 1.92, 95% CI 0.57-6.41), although this
finding was not statistically significant (Table 5). Similarly,
of those who had tried tampons, symptomatic women were
twice as likely to report a history of discomfort or pain with
first-time use (OR 2.15, 95% CI 1.0-4.62). A small but non-
significant portion of these women (6.1%) found their first
tampon experience so painful that they never used them
again.
Discussion and Conclusions
This is the first study of which we are aware that followed
a nationally selected group of women in a nonclinic setting
across time, assessing the incidence of vulvodynia-like
symptoms. This national telephone survey yielded a 4.7% in-
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TABLE 2. CHARACTERISTICS OF RESPONDERS AND NONRESPONDERS IN FOLLOW-UP SURVEYa
Responders Nonresponders
Characteristic (n  285) (n  140) p value
Age range, No. (%) 0.0001
18–24 years 7 (2.46%) 18 (12.86%)
25–34 years 36 (12.63%) 38 (27.14%)
35–44 years 57 (20%) 24 (17.14%)
45–54 years 66 (23.16%) 22 (15.71%)
55–64 years 53 (18.6%) 19 (13.57%)
65–80 years 66 (23.16%) 19 (13.57%)
Employment status, No.b (%) 0.068
Employed (full or part-time) 158 (57.66%) 90 (65.22%)
Student/homemaker 36 (13.14%) 20 (14.49%)
Unemployed 12 (4.38%) 9 (6.52%)
Retired 68 (24.82%) 19 (13.77%)
Marital status, No.c (%) 0.0005
Single, never married 27 (9.47%) 27 (19.57%)
Divorced/separated 22 (7.72%) 21 (15.22%)
Widowed 27 (9.47%) 6 (4.35%)
Married/marriagelike relationship 209 (73.33%) 84 (60.87%)
Education, No.d (%) 0.0112
High school or less 77 (27.02%) 49 (35.25%)
Some college/associate’s degree 88 (30.88%) 43 (30.94%)
College degree 72 (25.26%) 39 (28.06%)
Graduate degree 48 (16.84%) 8 (5.76%)
Race, No. (%) 0.0107
White 248 (87.02%) 106 (75.71%)
Black 18 (6.32%) 14 (10%)
Other 19 (6.67%) 20 (14.29%)
Overall health,e mean  SD 2.29  1.01 2.36  1.06
Quality of life,f mean  S.D. 8.34  4.99 9.68  12.29
Level of stress,g mean  S.D. 6.06  7.75 5.70  2.539
Depression, No. (%) 73 (25.61%) 45 (32.14%)
aBased on data provided in the original survey (Arnold et al.6).
bn  11 responders and n  2 nonresponders answered “other.”
cn  2 refused to provide relationship status.
dn  1 nonresponder answered “other.”
eSelf-reported on a 1–5 scale, where 1  excellent and 5  poor.
fSelf-reported on a 1–10 scale, where 1  worst possible and 10  best possible quality of life.
gSelf-reported on a 1–10 scale, where 1  least possible and 10  most possible amount of stress.
cidence of self-reported vulvar pain symptoms consistent
with vulvodynia, suggesting that as many as 1 in 20 women
experience new-onset genital pain lasting at least 6 months
within a 1-year period. It is acknowledged that this figure
may be an overestimate or underestimate of incidence, as it
is influenced by the fact that (new) symptom status of 112
women in the original asymptomatic group was unknown
at follow-up because of failure to recontact them. There may
be concern that response bias influenced participation and
thus affected the incidence estimate, but we believe this ef-
fect is minimal for two reasons. First, the survey was pre-
sented to women as “a follow-up to the women’s health sur-
vey you answered approximately one year ago” without
mention that occurrence of genital pain symptoms would be
assessed. This reduced the opportunity for refusal based on
not wanting to talk about (new) symptoms. Second, nearly
two thirds of nonresponse was the result of disconnected
numbers and subjects no longer at the residence (n  88 of
n  140 nonresponders); only 28 subjects (or 6.6% of the orig-
inal population) refused to participate. Thus, the majority of
nonresponse was not based on likelihood (or lack thereof) to
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FIG. 1. Characterization of vulvodynia-like symptoms (VLS) among 285 follow-up subjects.
TABLE 3. CHARACTERISTICS OF WOMEN WITH AND WITHOUT SELF-REPORTED
VULVODYNIA-LIKE SYMPTOMS
Asymptomatic Symptomatic
Characteristic (n  196) (n  52)
Age (mean  SD) 53.20  15.44 49.87  14.26
Overall health (mean  SD)a 2.47  0.97 2.44  0.98
Quality of life (mean  SD)b 7.86  1.44 7.94  1.36
Level of stress in life (mean  SD)b,c 5.34  2.29 6.35  2.16
Premenopausal (No., %) 90 (45.9%)0 22 (42.3%)0
Raced (No., %)
White 169 (86.22%) 47 (90.38%)
Black 12 (6.12%)0 2 (2.85%)0
Other 15 (7.65%)0 3 (5.77%)0
aReported as “excellent, very good, good, fair, poor” on a scale of 1–5, where 1  excellent and 5 
poor.
bReported on a scale of 1–10, where 1 is worst possible and 10 is best possible.
cp  0.05.
dOther includes Asian, Native American/Alaskan, Native Hawaiian/Pacific Islander, multiracial,
and self-described other.
inability to make contact with a viable number. Demographic
differences between the groups further support this argu-
ment. Specifically, nonresponders were younger and more
likely to be single or divorced/separated, with a higher pro-
portion of responders better educated and retired. These
characteristics are consistent with mobility among nonre-
sponders and stability among responders with regard to liv-
ing/employment situations and thus may explain the high
percentage of nonviable numbers. Should younger age be
positively correlated with vulvodynia, this would make our
calculation an underestimate of incidence. Conversely, if
none of the original 112 controls we failed to recontact ex-
perienced new symptoms, the most conservative estimate of
incidence would be 3.1%.
Although a number of vulvodynia studies require a min-
imum 3-month duration of symptoms for case defini-
tion,4,7,9,12,13 there is inconsistent evidence for using this time
frame for diagnostic purposes.14 As our study relied on self-
reported symptoms without a clinical confirmation of diag-
nosis, we chose a longer, more conservative time frame to
reduce the possibility of misclassification by subjects con-
fusing vulvodynia-like symptoms with other conditions that
might mimic vulvodynia but that resolve in a shorter time.
However, this stricter case definition criterion may have an
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TABLE 4. TRIGGERS OF VULVODYNIA-LIKE SYMPTOMS IN WOMEN WITH
AND WITHOUT SELF-REPORTED CHRONIC VULVAR PAIN
Asymptomatic Symptomatic
(n  195)a (n  52) Odds ratio
Situational pain No. (%) No. (%) (95% CI)
Tampon insertion 3 (1.5%) 14 (26.9%) 23.6 (6.46, 85.6)b
Speculum insertion 6 (3.1%) 14 (26.9%) 11.6 (4.19, 32.1)b
Intercourse 7 (3.6%) 27 (51.9%) 29.0 (11.44, 73.5)b
Exercise 0 (0.0%) 7 (13.7%)c 61.9 (3.69, 1175.3)b,d
n 
a1 control reported “don’t know” to all questions.
bp  0.05.
cn  1 reported “don’t know.”
dCorrection factor of 0.5 used for asymptomatic cell.
TABLE 5. CHARACTERISTICS OF TAMPON USE IN WOMEN WITH
AND WITHOUT SELF-REPORTED VULVODYNIA-LIKE SYMPTOMS
Asymptomatic Symptomatic
No. (%) No. (%) (95% CI)
Method of protection (n  196) (n  52)
Pads/sanitary napkins only 69 (35.2%) 13 (25%) 2 0.61 (0.31, 1.23)
Tampons only 49 (25%) 2 7 (13.5%) 0.47 (0.20, 1.10)
Both pads/sanitary napkins 78 (39.8%) 32 (61.5%) 2.42 (1.29, 4.53)a
and tampons
Primary reason for not using (n  68)b (n  13)
tampons
Unhygienic 3 (4.4%) 2 (15.4%) 3.94 (0.59, 26.3)
Feel uncomfortable 21 (30.9%) 6 (46.2%) 1.92 (0.57, 6.41)
Pain with insertion 5 (7.4%) 0 (0.0%) ––
Never tried tampons 15 (22.1%) 2 (15.4%) 0.64 (0.13, 3.22)
Other 24 (35.3%) 3 (23.1%) 0.55 (0.14, 2.19)
First tampon experience (n  166)c (n  48)d
Neither painful nor uncomfortable 60 (35.7%) 10 (20.4%) 1.0e
Uncomfortable but not painful 78 (46.4%) 29 (59.2%) 2.23 (1.0, 4.93)f
Painful the first time only 20 (11.9%) 6 (12.2%) 1.8 (0.58, 5.58)
So painful that never tried 8 (4.8%) 3 (6.1%) 2.25 (0.51, 9.95)
tampons again
Either painful or uncomfortableg 38 (79.17%) 106 (63.86%) 2.15 (1.0, 4.62)g
ap  0.005.
bn  1 refused to answer.
cn  28 never tried tampons, and 2 reported “don’t know.”
dn  3 never tried tampons, and 1 reported “don’t know.”
eServed as the referent group for odds ratio calculations.
fp  0.044.
gCalculated by combining “uncomfortable but not painful, painful the first time only, and so painful
never tried again”; marginally significant at p  0.046.
impact on the incidence measurement. Specifically, it is pos-
sible that some of the original controls experienced vulvo-
dynia-like symptoms within the time between studies, but
because of the relatively short follow-up period, these symp-
toms were present for less than 6 months. Thus, a longer fol-
low-up time (e.g., 2 years, 5 years, or 10 years) may better
capture new-onset chronic symptoms of such a long dura-
tion. The goal of this study was short term, however, and
aimed to examine how many women experienced new
symptoms within a year, which is the standard amount of
time between well-care gynecological or physical examina-
tions.
Interestingly, the stricter symptom duration criterion
adopted in this study may also explain why, at follow-up, 7
original controls unexpectedly reported vulvodynia-like
symptoms occurring prior to the original survey. Initially, it
seems that these women should have answered “yes” to the
vulvodynia symptom question on the initial survey and con-
sequently have been considered as original cases. However,
they may have begun to experience symptoms in the months
leading up to the original survey but not met the 6-month
definition until after the original survey passed. Conse-
quently, they would not have been characterized as cases
originally but would also have been missed in an incidence
calculation, as symptom onset occurred prior to the first sur-
vey and not during the period of interest, which was the time
between surveys. Had they been characterized as cases in
this situation, the incidence in this study would have been
7.9%.
Of note, there was a subset of original cases (n  36) who
reported vulvodynia-like symptoms at first contact but sub-
sequently denied lower genital tract pain at follow-up, a
finding that was not expected, as the case definition ques-
tion assessed “ever” as opposed to “currently” experiencing
vulvodynia-like symptoms. Because the survey did not in-
clude additional questions to probe for potential contradic-
tions in case answers, these women were removed from the
follow-up analysis because they could be confirmed as nei-
ther cases nor controls. We suggest several possible expla-
nations for this discrepancy in case reporting between orig-
inal and follow-up surveys. First, if subjects experienced a
resolution of symptoms, either spontaneously or secondary
to a medical intervention since the first telephone contact,
they may have misunderstood the question as assessing cur-
rent symptoms and thus answered negatively. This hypoth-
esis, in combination with the fact that approximately one
third of original cases reported no symptoms within the past
year, would be consistent with previous studies showing that
a subset of women will not report vulvar pain for more than
1 year.3,7,9,15
A prospective study by Peckham et al.15 followed 67
women with vulvar pain for 15 years and found that ap-
proximately 50% of subjects had spontaneous resolution of
their pain, with most remissions occurring within 6 months
of pain onset. Pharmacological or behavioral treatment can
also have a substantial impact on reduction of symp-
toms,16–18 with a recent study demonstrating complete
symptom resolution in 40% of patients treated with com-
bination antidepressent therapy for 6 months.19 Even if
symptoms had resolved, however, original cases still should
have answered “yes” to the vulvodynia screening question,
as it queried for lifetime history of symptoms. Alternately,
these cases may have denied symptoms because of embar-
rassment or discomfort as a result of the possibility of being
overheard by others in close proximity during the time of
the survey. Follow-up questions to probe such a discrepancy
should be considered in similar studies in the future. None-
theless, our data suggest that vulvodynia-like symptoms
may resolve in a subset of women, which highlights the need
for placebo-controlled trials when evaluating vulvar pain in-
terventions. Studies examining resolution of symptoms in di-
agnosed women would lend insight into possible treatments
and a better understanding of the natural course of disease
in afflicted women.
Consistent with other studies, we found vulvodynia-like
symptoms to be significantly related to the following situa-
tions: speculum insertion, intercourse, exercise, and tampon
use, especially first-time tampon use.4,6–9,20,21 Ten of the 14
symptomatic women who reported pain with tampon in-
sertion also reported pain with speculum insertion, demon-
strating that there is variation in symptoms even within the
commonality of insertional pain. Taken together, these char-
acteristics may serve to support the symptomatic population
as having a symptom history reflective of women diagnosed
with vulvodynia14 and to underscore the varied presenta-
tions of the disease. It is well documented that vulvodynia
has a significant negative effect on sexual functioning,22 with
dyspareunia in particular as a common complaint of diag-
nosed women.14 Thus, it is not surprising that intercourse
was the most notable situation in which symptomatic
women in our study experienced pain, with double the num-
ber of women suffering dyspareunia than pain in other in-
sertional circumstances. It is important to remember, how-
ever, that dyspareunia alone is not sufficient for diagnosis
of vulvodynia, as it may result from a myriad of conditions,
including vaginismus, interstitial cystitis, endometriosis, and
vaginal atrophy.23
Our original study with this national sample of women
found that women with vulvodynia-like symptoms had a
2.14 significantly increased odds of having ever used tam-
pons regularly compared with their asymptomatic counter-
parts.6 The temporal relationship between ever using tam-
pons and symptom onset was not assessed at that time,
however. In considering the pathogenesis of disease, it has
been suggested that inflammatory pathways and neu-
ropathies are involved in the development of vulvodynia.14
Other studies have considered the impact of early life effects
that introduce vestibular trauma (e.g., childhood abuse) on
the subsequent development of vulvodynia, with inconsis-
tent results.12,24,25 Thus, one hypothesis that stemmed from
the initial survey study was that in certain women, early reg-
ular tampon use was traumatic in that it damaged vestibu-
lar nerves or instigated inflammatory processes that later
manifested as vulvodynia. Although gaining information to
support this hypothesis is not possible from a survey alone,
this follow-up study served as an opportunity to further ex-
plore the association between experiences with tampons and
vulvodynia-like symptoms.
When asked about current preferred methods of men-
strual protection, symptomatic women were not only less
likely to use only tampons but also less likely to use only
sanitary napkins; rather they were nearly 2.5 times as likely
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to prefer a combination of tampons and napkins. This may
suggest that the “ever used tampons regularly” findings
characterized in the initial survey occurred prior to symp-
tom onset and that once women experienced chronic geni-
tal pain, tampons triggered or exacerbated symptomatic pe-
riods enough to encourage avoidance of solely using
tampons. Supporting this, symptomatic women were more
likely than their asymptomatic counterparts to not use tam-
pons because of physical discomfort, although associations
were not significant. Similarly, the chafing some women ex-
perience with sanitary napkins may also trigger or exacer-
bate symptoms and result in avoidance of this method of
protection. Thus, the preference symptomatic women ex-
hibited for a combination method of protection may reflect
differences in symptomatology (e.g., pain with insertion vs.
pressure or constant vs. intermittent pain) or timing of symp-
toms in relation to the menstrual cycle. It is difficult to as-
sess the extent of such associations because of the small sam-
ple size.
When considering initial tampon experiences, women
who reported symptoms consistent with vulvodynia were
2.15 times as likely to have experienced discomfort or pain
with first tampon use. This association is substantially lower
than the 7–8-fold risk reported most recently by Harlow and
Stewart7 but more consistent with the 2.4 increase in risk re-
ported in an earlier study by this same group.4 Even though
this experience was not severe enough to significantly pre-
vent women from ever trying tampons again, the extent of
pain or discomfort with first-time tampon insertion should
be examined as an early indicator of vulvodynia and, thus,
as a possible screening mechanism for early-stage disease.
The follow-up of this national sample of women indicates
that the annual occurrence of new-onset chronic genital pain
may be substantial. Although our study does not confirm
vulvodynia in any of the symptomatic patients, it has been
demonstrated that self-reported symptom history is a reli-
able means of assessing vulvodynia, with office examination
confirming disease in 96% of those who self-reported symp-
toms on a survey.13 This reliability of self-reporting, com-
bined with our finding that nearly 5% of previously asymp-
tomatic women indicated new vulvodynia-like symptoms
within a 12-month period, should serve to encourage the im-
portance of healthcare providers’ sensitivity to asking pa-
tients about (new-onset) chronic genital pain at annual ex-
aminations.
It is important to raise awareness about the condition and
for the clinical community to be proactive in asking patients
about chronic genital pain at routine annual examinations.
Although sample size limited the interpretation of tampon
findings, preliminary data suggest that the issues of first-
time tampon experiences and the way in which symptomatic
women handle their menstrual cycle are complex, making it
difficult to discern specific questions to assist with the diag-
nosis of vulvodynia. To truly understand how such mea-
surements relate to the incidence of vulvodynia, future large-
scale studies are needed in which physical examination or
medical record review is done to confirm whether self-re-
ported chronic vulvar pain symptoms are consistent with a
diagnosis of vulvodynia and to explore the issues raised here
about symptom resolution and tampon use in a diagnosed
population of women.
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